lyophilisation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-07-13 and is reviewed periodically as new material appears.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
| Property | Value | Notes |
|---|---|---|
| Receptor targets | GIP, GLP-1, glucagon | One molecule activates all three pathways |
| Research identifier | LY3437943 | Code used in published trial reports |
| Development stage | Phase 3, reported as ongoing | Not approved by any regulatory agency |
| Route studied | Subcutaneous | Administration form used in clinical trials |
| Studied populations | Adults with obesity or type 2 diabetes | Enrollment criteria vary between trials |
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. (21CFR312) Phase I/II trial
=== Russia and Ukraine === From 2013 to 2022 Galloway was a presenter on the Russian state-controlled television network RT. Galloway called the 2014 Ukrainian Revolution a Western-backed "coup" and a "foreign financed invasion of the sovereignty of Ukraine". He believes Russia's annexation of Crimea was legitimate, because he said the disputed 2014 Crimean status referendum showed that "the huge majority of people in Crimea wanted to leave Ukraine". In a 2016 interview of Nigel Farage, Galloway said "I respect Putin and I think he's very popular in Russia". When Russian opposition leader Alexei Navalny was poisoned in August 2020, Galloway claimed on RT that Navalny was a white supremacist. In early 2022, Galloway dismissed claims that Russia was about to invade Ukraine, writing "I told you it wasn't. You were wrong. I was right". When Russia invaded Ukraine ten days later, he said the invasion was "not what I wanted", but he blamed the invasion on "the West" and accused it of "Pumping Ukraine full of NATO weapons, mercenaries and propaganda". He suggested that the Bucha massacre was staged. Galloway was accused of being an apologist and propagandist for Russian president Vladimir Putin by the larger political parties. Jamie Blackett ended their political alliance All for Unity over their disagreement on Ukraine. The Scottish Liberal Democrats leader, Alex Cole-Hamilton, called Galloway "an apologist for Russian expansionist aggression" and said that Galloway's "association with RT has lent legitimacy and influence to the propaganda apparatus of a hostile power".
According to Minister of the Interior Juan Carlos Bidegain, the law was meant to "guarantee the security, national sovereignty and social and political stability of the country". Although Bukele stated that the law was modeled on the United States' Foreign Agents Registration Act (FARA), critics have compared it to Nicaraguan laws that institute press censorship by shutting down organizations and arresting journalists. Human Rights Watch reported on 16 December 2021 that 91 Twitter accounts belonging to journalists, lawyers, and activists were blocked by Bukele and governmental institutions. In October 2024, when investigative journalists published a report that found that Bukele, his three brothers, wife, and mother had purchased 34 properties valued at US$9 million during Bukele's first presidential term, Bukele referred to the journalists as "imbeciles" and denied accusations of corruption.
== Development == Valve developed Half-Life 2 (2004) over six years using its new game engine, Source. Instead of beginning work on a full sequel, Valve decided to create a series of episodic sequels. The designer Robin Walker said the team had become comfortable with their tools, and wanted to capitalize on their experience instead of developing new technologies. Valve's president, Gabe Newell, said customers would be happier with a new Half-Life game delivered in a shorter time rather than waiting years for another "monolithic product". In April 2005, Valve announced the game under the working title Aftermath. The title Episode One was announced in February 2006. In May, Valve announced that Episode One would be the first in a trilogy of episodic games to be released over the following two years. Newell said he considered the trilogy the equivalent of Half-Life 3. According to Newell, whereas the original Half-Life (1998) saw the G-Man transform Freeman into his tool, and Half-Life 2 saw Freeman being used by G-Man, the episodes would see G-Man lose control. While the plots and dialogue of Half-Life and Half-Life 2 were written solely by Marc Laidlaw, the Half-Life 2 episodes were written by Laidlaw and the new employees Chet Faliszek and Erik Wolpaw. Valve's focus was character development, particularly that of Gordon's companion Alyx, who accompanies the player for most of Episode One. Walker said it was ironic that the player spends most of Half-Life 2 alone despite the themes of "characters and other people".
Sources: en.wikipedia.org
=== Politburo === The politburo of SWAPO is a body that currently consists of 29 members for the period 2022–2027 (including party president, former party president, secretary general, deputy secretary general, members appointed by the party president and members elected by the SWAPO central committee for the period).
=== Malaria === Malaria and vitamin A deficiency are both common among young children in sub-Saharan Africa. Vitamin A supplementation to children in regions where vitamin A deficiency is common has repeatedly been shown to reduce overall mortality rates, especially from measles and diarrhea. For malaria, clinical trial results are mixed, either showing that vitamin A treatment did not reduce the incidence of probable malarial fever, or else did not affect incidence, but did reduce slide-confirmed parasite density and reduced the number of fever episodes. The question was raised as to whether malaria causes vitamin A deficiency, or vitamin A deficiency contributes to the severity of malaria, or both. Researchers proposed several mechanisms by which malaria (and other infections) could contribute to vitamin A deficiency, including a fever-induced reduction in synthesis of retinal-binding protein (RBP) responsible for transporting retinol from liver to plasma and tissues, but reported finding no evidence for a transient depression or restoration of plasma RBP or retinol after a malarial infection was eliminated.
== Disease associations == The vast majority of patients with positive HLA-B27 will not develop an associated syndrome. The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Though HLA-B27 is associated with a wide range of pathology, it does not appear to be the sole mediator in the development of disease. 90% of people with ankylosing spondylitis (AS) are HLA-B27 positive, although only a small fraction of people with HLA-B27 will develop AS. People who are HLA-B27 positive are more likely to experience early onset AS than HLA-B27 negative individuals. Research is uncovering other genes that predispose to AS and associated diseases, and there are potential environmental factors that may play a role in susceptible individuals. Approximately 40–50% of individuals with psoriatic arthritis have the HLA-B27 genotype. HLA-B27 is implicated in other types of seronegative spondyloarthropathy, such as reactive arthritis, acute anterior uveitis, iritis, Crohn's disease, and ulcerative colitis associated spondyloarthritis. The shared association with HLA-B27 leads to increased clustering of these diseases. HLA antigens have been studied in relation to autism.
During Mahathir's first tenure from 1981 to 2003, Malaysia experienced significant economic growth and modernisation, with his government promoting industry-wide privatisation and initiating major infrastructure projects, such as the North–South Expressway and the Kuala Lumpur City Centre. His policies were credited with transforming Malaysia into one of Southeast Asia's most dynamic emerging economies. He was a dominant political figure, securing five consecutive general election victories and maintaining leadership of the UMNO despite internal challenges. Mahathir continued pro-bumiputera policies and oversaw Malaysia's relatively swift recovery from the 1997 Asian financial crisis, aided by capital controls and stimulus measures that diverged from IMF prescriptions. As prime minister, he was a strong proponent of Asian values and alternative development models, and he played a prominent role in the Muslim world. In 1987, he ordered the detention of numerous activists under Operation Lalang, and his administration was involved in the 1988 Malaysian constitutional crisis, which raised concerns about judicial independence. He supported a constitutional amendment that stripped the royalty of criminal immunity, a move widely regarded as a legal reform strengthening the rule of law. In 1998, the dismissal of deputy Anwar Ibrahim sparked the Reformasi and became a major point of political debate in Malaysia.
When cannabis is cultivated for its psychoactive or medicinal properties, male plants will often be separated from females. This prevents fertilization of the female plants, either to facilitate sin semilla flowering or to provide more control over which male is chosen. Pollen produced by the male is caught and stored until it is needed. When a male plant of one strain pollinates a female of another strain, the seeds will be F1 hybrids of the male and female. These offspring will not be identical to their parents. Instead, they will have characteristics of both parents. Repeated breeding results in certain characteristics appearing with greater regularity. It is impossible for a hermaphrodite to create any male-only seeds. A hermaphrodite may create female only seeds and hermaphrodite seeds. Also the female-only seeds may carry the hermaphrodite trait. Hybridization is the process of plants and animals breeding. Natural wind currents help speed up this hybridization process and promotes a positive growth. Some plants produce many seeds while some produce little to none depending on how it is bred. If seeds are produced traits from both the original parents will be expressed. Techniques such as mutation breeding are used to develop new strains using irradiation or chemical mutagens such as colchicine. Various companies have been experimenting with creating new strains using genetic engineering techniques.
Sources: en.wikipedia.org
=== Breast cancer === In normal tissue, STAT5a mediates effects of prolactin in mammary glands. In breast cancer, STAT5a signaling is important for maintain tumor differentiation and suppressing disease progression. Studies originally showed a correlation between high STAT5a expression and tumor differentiation in mice models, but histopathological analysis of human breast cancer tissue has shown a different trend. It was shown that low nuclear levels of STAT5a was associated with unfavorable clinical outcomes and cancer progression independent of STAT5b expression. High STAT5a was suggested to be an inhibitor of invasion and metastasis and therefore an indicator of favorable clinical outcomes. Because of these trends, it has been proposed as a predictor of response to therapies such as anti-estrogen treatment.
1993/1579) Merchant Shipping (Prevention of Oil Pollution) (Amendment) Order 1993 (S.I. 1993/1580) Merchant Shipping (Prevention of Pollution by Garbage) (Amendment) Order 1993 (S.I. 1993/1581) International Carriage of Perishable Foodstuffs (Amendment) Regulations 1993 (S.I. 1993/1589) Swavesey Internal Drainage Board Award Drains Variation Order 1993 (S.I. 1993/1590) Wireless Telegraphy (Short Range Devices) (Exemption) Regulations 1993 (S.I. 1993/1591) Montrose Harbour Revision Order 1993 (S.I. 1993/1592) Local Government Superannuation (Scotland) Amendment Regulations 1993 (S.I. 1993/1593) Severn Bridge Regulations 1993 (S.I. 1993/1595)
== History == Lime sulfur is believed to be the earliest synthetic chemical used as a pesticide, having been used in France in the 1840s in order to control grapevine powdery mildew, Uncinula necator, which was introduced from the United States in 1845 and reduced wine production by 80%. In 1886, it was first used in California to control San Jose scale. Beginning around 1904, commercial suppliers began to manufacture lime sulfur; prior to that time, gardeners were expected to manufacture their own. By the 1920s, essentially all commercial orchards in Western countries were protected by regular spraying with lime sulfur. However, by the 1940s, lime sulfur began to be replaced by synthetic organic fungicides that posed less risk of damage to the crop's foliage.
=== Telomerase uses a built-in RNA template to maintain chromosome ends === Telomerase is an enzyme that is present in all eukaryotic nuclei which serves to maintain the ends of the linear DNA in the linear chromosomes of the eukaryotic nucleus, through the addition of terminal sequences that are lost in each round of DNA replication (telomeres). Before telomerase was identified, its activity was predicted on the basis of a molecular understanding of DNA replication, which indicated that the DNA polymerases known at that time could not replicate the 3′ end of a linear chromosome, due to the absence of a template strand. Telomerase was shown to be a ribonucleoprotein enzyme that contains an RNA component that serves as a template strand, and a protein component that has reverse transcriptase activity and adds nucleotides to the chromosome ends using the internal RNA template.
The science behind food and food production involves studying how food behaves and how it can be improved. Researchers analyze longevity and composition (i.e., ingredients, vitamins, minerals, etc.) of foods, as well as how to ensure food safety.
Sources: en.wikipedia.org
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.
No regulatory agency has approved it for any indication. It remains an investigational product studied within controlled clinical trial programs.
A dual agonist engages two receptor targets, typically GIP and GLP-1. A triagonist adds glucagon receptor activity, which is intended to influence energy expenditure alongside appetite and glucose handling.
It is described as a single molecule that acts at three receptors: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This triple activity distinguishes it from agents that target one or two of these pathways.